Adjuvant trastuzumab in HER2-positive breast cancer.
Slamon D; Eiermann W; Robert N; Pienkowski T; Martin M; Press M; Mackey J; Glaspy J; Chan A; Pawlicki M; Pinter T; Valero V; Liu MC; Sauter G; von Minckwitz G; Visco F; Bee V; Buyse M; Bendahmane B; Tabah-Fisch I; Lindsay MA; Riva A; Crown J; The New England Journal Of Medicine, 2011, vol. 365, issue 14, p 1273, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation